|
GB9127062D0
(en)
*
|
1991-12-20 |
1992-02-19 |
Unilever Plc |
Lip treatment composition
|
|
WO1994013257A1
(fr)
*
|
1992-12-16 |
1994-06-23 |
Creative Products Resource Associates, Ltd. |
Lotion occlusive ou semi-occlusive pour le traitement de maladies ou de desordres cutanes
|
|
JP3566739B2
(ja)
*
|
1993-09-30 |
2004-09-15 |
三省製薬株式会社 |
皮膚外用剤の安定化方法
|
|
AU3216695A
(en)
*
|
1994-08-29 |
1996-03-22 |
University Of North Carolina At Chapel Hill, The |
Lipid analogs for treating viral infections
|
|
US7135584B2
(en)
*
|
1995-08-07 |
2006-11-14 |
Wake Forest University |
Lipid analogs for treating viral infections
|
|
US5614489A
(en)
*
|
1995-05-25 |
1997-03-25 |
Mohammadi; Fatemeh |
Method and composition for treating the skin
|
|
FR2736827B1
(fr)
*
|
1995-07-21 |
1997-09-19 |
Boucher Christine Bernard |
Huile cosmetique extraite des plantes du genre calophyllum
|
|
FR2737118B1
(fr)
*
|
1995-07-28 |
1997-09-05 |
Oreal |
Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
|
|
US5932553A
(en)
*
|
1996-07-18 |
1999-08-03 |
The Regents Of The University Of California |
Illudin analogs useful as antitumor agents
|
|
US5723632A
(en)
|
1996-08-08 |
1998-03-03 |
Mgi Pharma, Inc. |
Total synthesis of antitumor acylfulvenes
|
|
DE19720083A1
(de)
*
|
1997-05-14 |
1998-11-19 |
Silvia Zender |
Arzneimittel
|
|
JP2001515886A
(ja)
*
|
1997-09-08 |
2001-09-25 |
ジョージタウン・ユニバーシティ |
Ｐｋｃの置換された２−ピロリジノン活性化剤
|
|
US6486214B1
(en)
|
1997-09-10 |
2002-11-26 |
Rutgers, The State University Of New Jersey |
Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
|
|
ATE219085T1
(de)
*
|
1997-12-29 |
2002-06-15 |
Res Corp Technologies Inc |
2-beta-substituierte-6-alkylidenpenizillansäure derivate als beta-laktamase inhibitoren
|
|
US6432941B1
(en)
|
1998-01-20 |
2002-08-13 |
Parker Hughes Institute |
Vanadium compounds for treating cancer
|
|
US6245808B1
(en)
|
1998-11-05 |
2001-06-12 |
Parker Hughes Institute |
Oxy-vanadium (IV) complexes having spermicidal activity
|
|
US6051603A
(en)
|
1998-01-20 |
2000-04-18 |
Wayne Hughes Institute |
Vanadium (IV) metallocene complexes having sperm motility inhibiting activity
|
|
US6025328A
(en)
|
1998-02-20 |
2000-02-15 |
The Regents Of The University Of California |
Antitumor agents
|
|
US7141603B2
(en)
*
|
1999-02-19 |
2006-11-28 |
The Regents Of The University California |
Antitumor agents
|
|
DE19825856A1
(de)
*
|
1998-06-10 |
1999-12-16 |
Labtec Gmbh |
Topische Arzneimittelzubereitung
|
|
US6355678B1
(en)
*
|
1998-06-29 |
2002-03-12 |
Parker Hughes Institute |
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
|
|
US6800649B1
(en)
|
1998-06-30 |
2004-10-05 |
Parker Hughes Institute |
Method for inhibiting c-jun expression using JAK-3 inhibitors
|
|
AUPP583198A0
(en)
*
|
1998-09-11 |
1998-10-01 |
Soltec Research Pty Ltd |
Mousse composition
|
|
US8263580B2
(en)
*
|
1998-09-11 |
2012-09-11 |
Stiefel Research Australia Pty Ltd |
Vitamin formulation
|
|
JP3211027B2
(ja)
*
|
1998-11-13 |
2001-09-25 |
丸石製薬株式会社 |
カプサイシン含有外用剤
|
|
US6080747A
(en)
*
|
1999-03-05 |
2000-06-27 |
Hughes Institute |
JAK-3 inhibitors for treating allergic disorders
|
|
JP2002539130A
(ja)
|
1999-03-09 |
2002-11-19 |
ファルマシア・アンド・アップジョン・カンパニー |
抗ウイルス剤としての４−オキソ−４，７−ジヒドロ−チエノ［２，３−ｂ］ピリジン−５−カルボキサミド
|
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
|
US6258820B1
(en)
|
1999-03-19 |
2001-07-10 |
Parker Hughes Institute |
Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
|
|
US6407091B1
(en)
*
|
1999-04-15 |
2002-06-18 |
Research Corporation Technologies, Inc. |
β-lactamase inhibiting compounds
|
|
US6930101B1
(en)
|
1999-05-17 |
2005-08-16 |
The Regents Of The University Of California |
Thiazolopyrimidines useful as TNFα inhibitors
|
|
CA2374003C
(fr)
*
|
1999-05-17 |
2008-02-12 |
Aesgen, Inc. |
Assimilation cellulaire amelioree d'agents bioactifs
|
|
WO2000078793A2
(fr)
|
1999-06-22 |
2000-12-28 |
University Of Louisville Research Foundation, Inc. |
Agents antimicrobiens
|
|
US6670341B1
(en)
|
1999-10-28 |
2003-12-30 |
Wake Forest University Health Sciences |
Compositions and methods for double-targeting virus infections and targeting cancer cells
|
|
US7026469B2
(en)
*
|
2000-10-19 |
2006-04-11 |
Wake Forest University School Of Medicine |
Compositions and methods of double-targeting virus infections and cancer cells
|
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
|
WO2001036431A1
(fr)
|
1999-11-15 |
2001-05-25 |
Parker Hughes Institute |
Complexes antitumoraux a base de diamino platine (ii)
|
|
US6649654B1
(en)
*
|
1999-11-23 |
2003-11-18 |
The Regents Of The University Of California |
Methods for identifying and using IKK inhibitors
|
|
US6589992B2
(en)
|
1999-11-30 |
2003-07-08 |
Parker Hughes Institute |
Inhibiting collagen-induced platelet aggregation
|
|
IL133968A0
(en)
*
|
2000-01-10 |
2001-04-30 |
Thixo Ltd |
Therapeutic oils and edible pastes containing the same
|
|
US6967023B1
(en)
*
|
2000-01-10 |
2005-11-22 |
Foamix, Ltd. |
Pharmaceutical and cosmetic carrier or composition for topical application
|
|
KR20020093849A
(ko)
|
2000-03-21 |
2002-12-16 |
파마시아 앤드 업존 캄파니 |
항바이러스제로서의4-옥소-1,4-디히드로[1,8]나프티리딘-3-카르복스아미드
|
|
CA2399741A1
(fr)
|
2000-03-21 |
2001-11-01 |
Scott D. Larsen |
4-hydroxycinnoline-3-carboxyamides utilises comme agents antiviraux
|
|
NZ521523A
(en)
|
2000-03-21 |
2004-05-28 |
Upjohn Co |
4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
|
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
|
US6682892B2
(en)
|
2000-07-13 |
2004-01-27 |
Pharmacia & Upjohn Company |
Method for treating herpes viruses
|
|
US6696441B1
(en)
|
2000-08-11 |
2004-02-24 |
The Regents Of The University Of California |
Inhibition of p53-induced stress response
|
|
US6689767B2
(en)
|
2000-09-29 |
2004-02-10 |
Regents Of The University Of Minnesota |
Triterpenes having antibacterial activity
|
|
JP2004509972A
(ja)
|
2000-09-29 |
2004-04-02 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
酵母に対する殺真菌活性を有するトリテルペン
|
|
US6951847B2
(en)
*
|
2000-09-29 |
2005-10-04 |
Regents Of The University Of Minnesota |
Methods of treating fungal infections using lupeol
|
|
US7309696B2
(en)
|
2000-10-19 |
2007-12-18 |
Wake Forest University |
Compositions and methods for targeting cancer cells
|
|
US6958359B1
(en)
|
2000-11-15 |
2005-10-25 |
Parker Hughes Institute |
Vanadium compounds as anti-angiogenic agents
|
|
US6642221B1
(en)
|
2000-11-15 |
2003-11-04 |
Parker Hughes Institute |
Vanadium compounds as anti-proliferative agents
|
|
US6878388B1
(en)
|
2000-11-15 |
2005-04-12 |
Parker Hughes Institute |
Vanadium compounds for treating proliferative cell disorders
|
|
US6630462B2
(en)
|
2000-11-17 |
2003-10-07 |
Adolor Corporation |
Delta agonist analgesics
|
|
US7250172B2
(en)
*
|
2001-01-31 |
2007-07-31 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
|
US7261901B2
(en)
*
|
2001-01-31 |
2007-08-28 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
|
US7232829B2
(en)
*
|
2001-04-06 |
2007-06-19 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
KR20030041130A
(ko)
*
|
2001-05-29 |
2003-05-23 |
코닌클리케 필립스 일렉트로닉스 엔.브이. |
금속-세라믹 접착
|
|
US7601846B2
(en)
*
|
2001-06-26 |
2009-10-13 |
The Regents Of The University Of California |
Compounds having activity as inhibitors of apoptosis
|
|
US20030232794A1
(en)
*
|
2001-06-26 |
2003-12-18 |
Cottam Howard B. |
Use of STAT-6 inhibitors as therapeutic agents
|
|
US6916801B2
(en)
*
|
2001-07-24 |
2005-07-12 |
Alamx, Llc |
7-Alkylidene-3-substituted-3-cephem-4-carboxylates as β-lactamase inhibitors
|
|
US20030171377A1
(en)
*
|
2001-08-29 |
2003-09-11 |
Bigge Christopher Franklin |
Antidiabetic agents
|
|
MXPA04001917A
(es)
*
|
2001-08-31 |
2004-06-15 |
Thomson Licensing Sa |
Contador de secuencia para una corriente audio-visual.
|
|
US20050129680A1
(en)
*
|
2001-09-17 |
2005-06-16 |
Paul Wentworth |
Antimicrobial activity of antibodies
|
|
US20040116350A1
(en)
*
|
2001-09-17 |
2004-06-17 |
Paul Wentworth Jr |
Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
|
|
US20040157280A1
(en)
*
|
2001-09-17 |
2004-08-12 |
Paul Wentworth |
Antibody mediated ozone generation
|
|
AU2002362443B2
(en)
*
|
2001-10-01 |
2008-05-15 |
University Of Virginia Patent Foundation |
2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
|
|
WO2003031587A2
(fr)
*
|
2001-10-09 |
2003-04-17 |
The Regents Of The University Of California |
Utilisation d'inhibiteurs de stat-6 comme agents therapeutiques
|
|
AU2002363658B2
(en)
|
2001-11-14 |
2008-09-11 |
Rutgers, The State University |
Solubilized topoisomerase poisons
|
|
CA2466039A1
(fr)
*
|
2001-11-23 |
2003-06-05 |
Rutgers, The State University |
Synthese amelioree de polyanhyrides
|
|
US7030141B2
(en)
|
2001-11-29 |
2006-04-18 |
Christopher Franklin Bigge |
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
|
|
AU2003205332A1
(en)
*
|
2002-01-25 |
2003-09-02 |
Philip S. Portoghese |
Selective analgesic agents
|
|
WO2003087105A1
(fr)
*
|
2002-04-04 |
2003-10-23 |
Alamx, L.L.C. |
INHIBITEURS DE SERINE ET DE METALLO-ss-LACTAMASES
|
|
AUPS158502A0
(en)
*
|
2002-04-08 |
2002-05-16 |
Dermcare-Vet Pty Ltd |
Allergic dermatitis composition and method of treatment
|
|
WO2003086408A1
(fr)
*
|
2002-04-10 |
2003-10-23 |
University Of Virginia Patent Foundation |
Utilisation d'agonistes du recepteur d'adenosine a2a dans le traitement de maladies inflammatoires
|
|
US20040156799A1
(en)
*
|
2002-06-04 |
2004-08-12 |
Zigang Dong |
Cancer treatment method and compositions
|
|
UA79293C2
(en)
*
|
2002-07-03 |
2007-06-11 |
Univ Wayne State |
4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
|
|
NZ538405A
(en)
*
|
2002-08-01 |
2007-12-21 |
Aesgen Inc |
Improved treatment of cancer with glutamine and carbohydrate
|
|
US6989387B2
(en)
*
|
2002-08-09 |
2006-01-24 |
Rutgers, The State University Of New Jersey |
Nitro and amino substituted topoisomerase agents
|
|
US7438918B2
(en)
*
|
2002-08-30 |
2008-10-21 |
University Of Iowa Research Foundation |
Lipid A deficient mutants of Neisseria meningitidis
|
|
JP2005538175A
(ja)
*
|
2002-09-11 |
2005-12-15 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
血液凝固過程に関与する第Ｘａ因子および他セリンプロテアーゼのインヒビター
|
|
EP2447278B1
(fr)
|
2002-10-10 |
2015-04-08 |
Cornell Research Foundation, Inc. |
Nouvelles protéines immunogènes de Leptospira
|
|
EP1552025A4
(fr)
*
|
2002-10-18 |
2006-12-13 |
Cylene Pharmaceuticals Inc |
Procedes servant a identifier des molecules antivirales ciblees vers des structures quadruplex
|
|
US20060140984A1
(en)
|
2002-10-25 |
2006-06-29 |
Foamix Ltd. |
Cosmetic and pharmaceutical foam
|
|
IL152486A0
(en)
*
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
|
US20080206161A1
(en)
*
|
2002-10-25 |
2008-08-28 |
Dov Tamarkin |
Quiescent foamable compositions, steroids, kits and uses thereof
|
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
|
US20080317679A1
(en)
*
|
2002-10-25 |
2008-12-25 |
Foamix Ltd. |
Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
|
|
US7704518B2
(en)
*
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
|
US20050205086A1
(en)
*
|
2002-10-25 |
2005-09-22 |
Foamix Ltd. |
Retinoid immunomodulating kit and composition and uses thereof
|
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
|
US20060193789A1
(en)
*
|
2002-10-25 |
2006-08-31 |
Foamix Ltd. |
Film forming foamable composition
|
|
US20050186142A1
(en)
*
|
2002-10-25 |
2005-08-25 |
Foamix Ltd. |
Kit and composition of imidazole with enhanced bioavailability
|
|
US20070292355A1
(en)
*
|
2002-10-25 |
2007-12-20 |
Foamix Ltd. |
Anti-infection augmentation foamable compositions and kit and uses thereof
|
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
|
US20070292359A1
(en)
*
|
2002-10-25 |
2007-12-20 |
Foamix Ltd. |
Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
|
|
US8119109B2
(en)
*
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
|
US20050271596A1
(en)
*
|
2002-10-25 |
2005-12-08 |
Foamix Ltd. |
Vasoactive kit and composition and uses thereof
|
|
US20060018937A1
(en)
*
|
2002-10-25 |
2006-01-26 |
Foamix Ltd. |
Steroid kit and foamable composition and uses thereof
|
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
|
US8486376B2
(en)
*
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
|
US7544674B2
(en)
*
|
2002-10-25 |
2009-06-09 |
Galderma S.A. |
Topical skin care composition
|
|
NZ540194A
(en)
|
2002-11-08 |
2008-07-31 |
Ablynx Nv |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
EP1558645B1
(fr)
|
2002-11-08 |
2011-07-27 |
Ablynx N.V. |
Anticorps a domaine unique stabilises dans une composition pharmaceutique pour inhalation
|
|
CN100570365C
(zh)
*
|
2002-11-14 |
2009-12-16 |
斯克里普斯研究所 |
抗体或嗜中性粒细胞介导的臭氧产生
|
|
US7297340B2
(en)
*
|
2003-01-07 |
2007-11-20 |
University Of Iowa Research Foundation |
Vaccine and method for preventing biofilm formation
|
|
US20050079512A1
(en)
*
|
2003-02-26 |
2005-04-14 |
Emerson Beverly M. |
Methods of modulating gene expression
|
|
US7354916B2
(en)
*
|
2003-04-07 |
2008-04-08 |
Cylene Pharmaceuticals |
Substituted quinobenzoxazine analogs
|
|
US7163948B2
(en)
*
|
2003-04-07 |
2007-01-16 |
Cylene Pharmaceuticals, Inc. |
Heterocyclic substituted 1,4-dihydri-4ox9-1,8-naphthyridine analogs
|
|
JP2006522827A
(ja)
*
|
2003-04-07 |
2006-10-05 |
サイリーン ファーマシューティカルズ インコーポレーティッド |
置換キノベンゾオキサジン類似体
|
|
US7507727B2
(en)
*
|
2003-04-07 |
2009-03-24 |
Cylene Pharmaceuticals, Inc. |
Substituted quinobenzoxazine analogs and methods of using thereof
|
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
|
PL1653943T6
(pl)
|
2003-06-25 |
2009-02-27 |
The Burnham Inst La Jolla |
Pochodne katecholu do leczenia raka
|
|
WO2005003140A1
(fr)
*
|
2003-07-02 |
2005-01-13 |
Pharmacia & Upjohn Company Llc |
4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides utilises comme agents antiviraux
|
|
US7169401B2
(en)
*
|
2003-07-18 |
2007-01-30 |
Hill Dermaceuticals, Inc. |
Topical skin care composition containing refined peanut oil
|
|
US20070140999A1
(en)
*
|
2003-07-18 |
2007-06-21 |
Hill Dermaceuticals, Inc. |
Topical skin care composition containing refined peanut oil
|
|
US8486374B2
(en)
*
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
|
EP1658291B1
(fr)
|
2003-08-25 |
2013-10-02 |
Dogwood Pharmaceuticals, Inc. |
Xanthines de 8-heteroaryle substituees
|
|
US9532994B2
(en)
|
2003-08-29 |
2017-01-03 |
The Regents Of The University Of California |
Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
|
|
US20060099173A1
(en)
*
|
2003-10-24 |
2006-05-11 |
Nancy Puglia |
Topical skin care composition
|
|
PT1687338E
(pt)
|
2003-11-07 |
2011-01-20 |
Ablynx Nv |
Anticorpos de domínio único vhh de camelídeos direccionados para o receptor do factor de crescimento epidérmico e suas utilizações
|
|
EP2299266A1
(fr)
*
|
2003-12-19 |
2011-03-23 |
The Regents of the University of California |
Procédés et matériels pour évaluer les thérapies du cancer de la prostate
|
|
AU2005201455A1
(en)
*
|
2004-02-04 |
2005-08-25 |
Foamix Ltd. |
Cosmetic and pharmaceutical foam with solid matter
|
|
WO2005077377A1
(fr)
*
|
2004-02-06 |
2005-08-25 |
Regents Of The University Of Minnesota |
Compositions comprenant un triterpene et un excipient
|
|
CA2557433C
(fr)
|
2004-02-19 |
2013-05-14 |
Rexahn Corporation |
Derives de quinazoline et leur utilisation therapeutique
|
|
US20050187192A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Pharmaceutical Company |
Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
|
|
US20050187191A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Louis S. |
Methods and compositions for the treatment of respiratory syncytial virus
|
|
NZ550102A
(en)
*
|
2004-02-24 |
2010-10-29 |
Univ California |
Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
|
|
CN1984663A
(zh)
|
2004-03-29 |
2007-06-20 |
南佛罗里达大学 |
用曲西瑞宾和相关化合物有效治疗肿瘤和癌症
|
|
NZ585697A
(en)
|
2004-08-02 |
2011-12-22 |
Univ Virginia Patent Found |
2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity
|
|
WO2006028618A1
(fr)
*
|
2004-08-02 |
2006-03-16 |
University Of Virginia Patent Foundation |
Analogues d'adenosine de propynyle 2-polycyclique presentant des groupes 5'-ribose modifies presentant une activite agoniste de a2a
|
|
EP1793832B1
(fr)
*
|
2004-08-25 |
2014-07-23 |
University of Iowa Research |
Inhibiteurs de la geranylgeranyl pyrophosphate synthase
|
|
US7718680B2
(en)
*
|
2004-09-23 |
2010-05-18 |
Burnham Institute For Medical Research |
Inhibition of lethal factor protease activity from anthrax toxin
|
|
WO2006040153A2
(fr)
*
|
2004-10-13 |
2006-04-20 |
Ablynx N.V. |
Nanocorps™ contre la proteine beta-amyloide et polypeptides les renfermant pour le traitement de maladies degeneratives neurales, telles que la maladie d'alzheimer
|
|
US8697674B2
(en)
*
|
2004-12-29 |
2014-04-15 |
Naturon, Inc. |
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
|
|
CA2594542C
(fr)
*
|
2005-01-10 |
2014-03-25 |
University Of Virginia Patent Foundation |
Synthese d'inhibiteurs de p90rsk
|
|
BRPI0612448A2
(pt)
*
|
2005-05-09 |
2010-11-23 |
Foamix Ltd |
composição espumosa de sacarìdeo
|
|
NZ564223A
(en)
|
2005-05-13 |
2011-03-31 |
Univ California |
Diarylhydantoin compounds for treating hormone refractory prostate cancer
|
|
US7709517B2
(en)
*
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
|
AU2006249144B2
(en)
|
2005-05-18 |
2011-11-17 |
Ablynx Nv |
Improved NanobodiesTM against Tumor Necrosis Factor-alpha
|
|
LT2444424T
(lt)
|
2005-05-20 |
2018-10-25 |
Ablynx N.V. |
Pagerintos tm nanodalelės, skirtos agregacijos sąlygotų sutrikimų gydymui
|
|
ES2447301T3
(es)
|
2005-06-01 |
2014-03-11 |
Glaxosmithkline Intellectual Property Development Limited |
Formulación vitamínica
|
|
US20080152596A1
(en)
*
|
2005-07-19 |
2008-06-26 |
Foamix Ltd. |
Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
|
|
WO2007019308A2
(fr)
*
|
2005-08-03 |
2007-02-15 |
The Regents Of The University Of California |
Analogues d'illudine utiles en tant qu'agents anticancereux
|
|
CA2620182A1
(fr)
|
2005-08-22 |
2007-03-01 |
Dennis A. Carson |
Agonistes tlr
|
|
US20070098660A1
(en)
*
|
2005-10-27 |
2007-05-03 |
Jim Taneri |
Methods and compositions for epilation
|
|
US20070098667A1
(en)
*
|
2005-10-27 |
2007-05-03 |
Jim Taneri |
Methods and compositions for epilation
|
|
WO2007056113A2
(fr)
*
|
2005-11-02 |
2007-05-18 |
Cylene Pharmaceuticals, Inc. |
Procedes de ciblage de sequences quadruplex
|
|
WO2007120972A2
(fr)
*
|
2006-02-10 |
2007-10-25 |
University Of Virginia Patent Foundation |
Procede permettant de traiter l'anemie a hematies falciformes
|
|
AU2007217366A1
(en)
|
2006-02-27 |
2007-08-30 |
The Regents Of The University Of California |
Oxysterol compounds and the hedgehog pathway
|
|
CA2647038A1
(fr)
*
|
2006-03-22 |
2007-10-04 |
The Regents Of The University Of California |
Inhibiteurs de prenyltransferases proteiques
|
|
BRPI0709771B1
(pt)
|
2006-03-27 |
2022-01-25 |
The Regents Of The University Of California |
Composto e composição farmacêutica
|
|
NZ596260A
(en)
*
|
2006-03-29 |
2013-05-31 |
Univ California |
Diarylthiohydantoin compounds
|
|
US8093235B2
(en)
|
2006-04-25 |
2012-01-10 |
Rutgers, The State University Of New Jersey |
Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
|
|
WO2007139778A2
(fr)
*
|
2006-05-22 |
2007-12-06 |
University Of Virginia Patent Foundation |
Influence des substituants de rhamnose sur la puissance de sl0101, un inhibiteur de la ser/thr kinase, rsk
|
|
US20110112086A1
(en)
*
|
2006-06-08 |
2011-05-12 |
Cylene Pharmaceuticals, Inc. |
Pyridinone analogs
|
|
WO2007146831A2
(fr)
*
|
2006-06-08 |
2007-12-21 |
Cylene Pharmaceuticals, Inc. |
Analogues de quinolone dérivés avec de l'acide sulfonique, du sulfonate ou du sulfonamide
|
|
US8188063B2
(en)
*
|
2006-06-19 |
2012-05-29 |
University Of Virginia Patent Foundation |
Use of adenosine A2A modulators to treat spinal cord injury
|
|
CN101563058A
(zh)
*
|
2006-09-08 |
2009-10-21 |
弗米克斯有限公司 |
有色的或可着色的能起泡的组合物和泡沫
|
|
US20080260655A1
(en)
*
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
|
AU2007356328A1
(en)
*
|
2006-11-14 |
2009-01-15 |
Tal Berman |
Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
|
|
US8034829B2
(en)
|
2006-11-17 |
2011-10-11 |
Rexahn Pharmaceuticals, Inc. |
5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereof
|
|
WO2008065503A1
(fr)
*
|
2006-11-29 |
2008-06-05 |
Pfizer Products Inc. |
1- [ ( 4 -chlorophényl) amide 5-{[2-fluoro-4- (2-oxo-2h-pyridin-1-yl) -phényl]amide) d'acide (r) -5-méthyl-4, 5-dihydro- pyrazole-1, 5-dicarboxylique servant d'inhibiteur du facteur xa
|
|
US9156914B2
(en)
|
2006-12-19 |
2015-10-13 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
|
|
AU2007336242B2
(en)
|
2006-12-19 |
2012-08-30 |
Ablynx N.V. |
Amino acid sequences directed against GPCRs and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
|
|
EP2111385B1
(fr)
|
2007-02-06 |
2014-11-12 |
University Of Louisville Research Foundation, Inc. |
Alcynes substitués comme agents antitumoraux
|
|
EP2510946B1
(fr)
|
2007-02-07 |
2015-08-05 |
The Regents of The University of California |
Conjugués d'agonistes synthétiques de tlr et leurs utilisations
|
|
WO2008103818A1
(fr)
*
|
2007-02-21 |
2008-08-28 |
University Of Louisville Research Foundation |
Compositions thérapeutiques à base de cotinine
|
|
US8569449B2
(en)
|
2007-05-08 |
2013-10-29 |
University Of Louisville Research Foundation, Inc. |
Synthetic peptides and peptide mimetics
|
|
CN101743007B
(zh)
|
2007-07-12 |
2015-04-08 |
南佛罗里达大学 |
具有抗肿瘤活性的akt/pkb抑制剂
|
|
MX2010001303A
(es)
|
2007-08-02 |
2010-09-07 |
Univ Rutgers |
Compuestos terapeuticos.
|
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
|
KR101601332B1
(ko)
*
|
2007-10-05 |
2016-03-08 |
센화 바이오사이언시즈 인코포레이티드 |
퀴놀론 유사체 및 이와 관련된 방법
|
|
US9115061B2
(en)
*
|
2007-10-19 |
2015-08-25 |
Burnham Institute For Medical Research |
Naphthalene-based inhibitors of anti-apoptotic proteins
|
|
WO2009055677A1
(fr)
*
|
2007-10-24 |
2009-04-30 |
University Of South Florida |
Disulfures s-hétérosubstitués antibactériens
|
|
TWI469971B
(zh)
|
2007-10-26 |
2015-01-21 |
Univ California |
二芳基乙內醯脲類化合物
|
|
US20090130029A1
(en)
*
|
2007-11-21 |
2009-05-21 |
Foamix Ltd. |
Glycerol ethers vehicle and pharmaceutical compositions thereof
|
|
WO2009069006A2
(fr)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Peroxyde de benzoyle contenant de la mousse
|
|
US9526737B2
(en)
|
2007-12-03 |
2016-12-27 |
The Regents Of The University Of California |
Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and Wnt signaling
|
|
WO2010041141A2
(fr)
|
2008-10-07 |
2010-04-15 |
Foamix Ltd. |
Support expansible à base d’huile et préparations
|
|
WO2009072007A2
(fr)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Porteurs, formulations, procédés pour formuler des agents actifs instables pour application externe et utilisations associées
|
|
US8058259B2
(en)
*
|
2007-12-20 |
2011-11-15 |
University Of Virginia Patent Foundation |
Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
|
AU2009205314A1
(en)
*
|
2008-01-14 |
2009-07-23 |
Foamix Ltd. |
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
|
|
US8142764B2
(en)
|
2008-02-27 |
2012-03-27 |
University Of Louisville Research Foundation |
Synthetic biofilm-inhibiting peptides
|
|
WO2009114539A2
(fr)
*
|
2008-03-10 |
2009-09-17 |
University Of Louisville Research Foundation |
Traitements neuroprotecteurs à base de peptide de liaison de l'intégrine et de l'angiopoïétine-1
|
|
WO2009114921A1
(fr)
*
|
2008-03-17 |
2009-09-24 |
Dmitrienko Gary I |
INHIBITEURS DE β-LACTAMASES DE CLASSE B ET DE CLASSE D
|
|
WO2009146112A1
(fr)
*
|
2008-04-02 |
2009-12-03 |
University Of Virginia Patent Foundation |
Compositions et procédés pour inhiber la sphingosine kinase
|
|
US8557965B2
(en)
|
2008-04-07 |
2013-10-15 |
Ablynx N.V. |
Single variable domains against notch pathway members
|
|
AU2009236303B2
(en)
|
2008-04-16 |
2014-12-04 |
Howard University |
Inhibitors of Protein Phosphatase-1 and uses thereof
|
|
US9212226B2
(en)
|
2008-05-16 |
2015-12-15 |
Ablynx N.V. |
Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the same
|
|
US9872867B2
(en)
*
|
2008-06-06 |
2018-01-23 |
Tanya Kuritz |
Methods and compositions for modulation of innate immunity
|
|
US8673910B2
(en)
*
|
2008-06-30 |
2014-03-18 |
H. Lee Moffitt Cancer Center And Research Institute |
Proteasome inhibitors for selectively inducing apoptosis in cancer cells
|
|
US20090324506A1
(en)
*
|
2008-06-30 |
2009-12-31 |
Jeffery Richard Seidling |
Sprayable skin protectant formulation and method of use
|
|
US7947717B2
(en)
*
|
2008-07-18 |
2011-05-24 |
Burnham Institute For Medical Research |
Inhibitors of lethal factor protease
|
|
WO2010011666A2
(fr)
*
|
2008-07-21 |
2010-01-28 |
University Of South Florida |
Inhibiteurs de shp-2 à squelette indoline et procédé de traitement du cancer
|
|
US9125821B2
(en)
|
2008-07-28 |
2015-09-08 |
The Regents Of The University Of California |
Nanodrug targeting protein geranylgeranylation
|
|
WO2010014054A1
(fr)
|
2008-07-28 |
2010-02-04 |
The Regents Of The University Of California |
Inhibiteurs de prényltransférases de protéine
|
|
US9132168B2
(en)
|
2008-08-05 |
2015-09-15 |
University Of South Florida |
Methods of treating cognitive impairment
|
|
CN102215860A
(zh)
*
|
2008-08-05 |
2011-10-12 |
南佛罗里达大学 |
治疗认知损害的方法
|
|
CA2733458A1
(fr)
*
|
2008-08-08 |
2010-02-11 |
University Of Florida Research Foundation, Inc. |
Composes lipidiques pour suppression de tumorigenese
|
|
US9480691B1
(en)
*
|
2009-01-20 |
2016-11-01 |
Hill Dermaceuticals, Inc. |
Topical liquid containing refined peanut oil for treating skin proliferation or inflammation disorders
|
|
TW201038578A
(en)
|
2009-01-30 |
2010-11-01 |
Univ Rutgers |
Methods to treat cancer
|
|
CN102438619A
(zh)
|
2009-03-20 |
2012-05-02 |
衣阿华大学研究基金会 |
作为抗结核剂的异戊二烯化双膦酸盐
|
|
MX2011010681A
(es)
|
2009-04-10 |
2012-01-20 |
Ablynx Nv |
Secuencias mejoradas de aminoacidos dirigidas contra il-6r y polipeptidos que comprenden el mismo para el tratamiento de enfermedades y trastornos relacionados con il-6r.
|
|
US8487131B2
(en)
|
2009-04-15 |
2013-07-16 |
Sanford-Burnham Medical Research Institute |
Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
|
|
BRPI1016102A2
(pt)
|
2009-04-15 |
2015-09-01 |
Sanford Burhnham Medical Res Inst |
Inibidores de proteínas anti-apoptótica baseados em naftaleno
|
|
US20120087872A1
(en)
|
2009-04-28 |
2012-04-12 |
Foamix Ltd. |
Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
|
|
WO2010132684A2
(fr)
|
2009-05-13 |
2010-11-18 |
University Of Virginia Patent Foundation |
Inhibiteurs de leucémie inv(16)
|
|
EP2448953A1
(fr)
|
2009-06-30 |
2012-05-09 |
Forest Laboratories Holdings Limited |
Composés alcoxy-carbonyl-amino-alcynyle-adénosine et dérivés de ceux-ci en tant qu'agonistes de a2ar
|
|
WO2011005871A1
(fr)
|
2009-07-07 |
2011-01-13 |
Pgxhealth, Llc |
8-[6-carbonylamino-3-pyridyle] xanthines substituées en tant quantagonistes de ladénosine a2b
|
|
WO2011013009A2
(fr)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Compositions hydro-alcooliques moussantes non tensioactives, mousses légères, et leurs utilisations
|
|
CA2769677A1
(fr)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Compositions hydro-alcooliques moussantes a base d'agents non tensioactifs non polymeres, mousses legeres, et leurs utilisations
|
|
JP2013501003A
(ja)
|
2009-07-31 |
2013-01-10 |
バイオクライスト ファーマシューティカルズ， インコーポレイテッド |
ヤヌスキナーゼ阻害剤としてのピロロ［１，２−ｂ］ピリダジン誘導体
|
|
WO2011019995A2
(fr)
|
2009-08-14 |
2011-02-17 |
Hecht Sidney M |
Synthèse et identification de nouveaux inhibiteurs spécifiques de la rsk
|
|
TW201111385A
(en)
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
|
US8642088B2
(en)
|
2009-09-04 |
2014-02-04 |
Wisconsin Alumni Research Foundation |
Tannin-chitosan composites
|
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
|
AU2010302350B2
(en)
|
2009-10-02 |
2015-06-18 |
Journey Medical Corporation |
Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
|
|
EP2485721A4
(fr)
*
|
2009-10-08 |
2016-05-18 |
Sanford Burnham Med Res Inst |
Dérivés d'apogossypolone en tant qu'agents anticancéreux
|
|
US8796300B2
(en)
|
2009-11-05 |
2014-08-05 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds
|
|
RU2012130929A
(ru)
|
2009-12-23 |
2014-01-27 |
Байокрист Фармасьютикалз, Инк. |
Гетероциклические соединения в качестве ингибиторов янус-киназы
|
|
US9096544B2
(en)
|
2009-12-23 |
2015-08-04 |
Wayne State University |
Therapeutic compounds
|
|
EP3124481B1
(fr)
|
2010-02-16 |
2018-03-28 |
Aragon Pharmaceuticals, Inc. |
Modulateurs de récepteur d'androgène et utilisations associées
|
|
CA2828114A1
(fr)
|
2010-02-26 |
2011-09-01 |
Gary Igor DMITRIENKO |
Derives de la cephalosporine utiles comme inhibiteurs de la .beta.-lactamase et leurs compositions et procedes d'utilisation
|
|
US20130023585A1
(en)
|
2010-04-02 |
2013-01-24 |
Tsrl, Inc. |
Neuraminidase Inhibitors
|
|
US12661407B2
(en)
|
2010-04-08 |
2026-06-23 |
Journey Medical Corporation |
Compositions, gels and foams with rheology modulators and uses thereof
|
|
US9221808B2
(en)
|
2010-04-16 |
2015-12-29 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinase (ROCK) and methods of use
|
|
WO2011133696A2
(fr)
|
2010-04-20 |
2011-10-27 |
Regents Of The University Of Minnesota |
Méthodes de lutte contre l'athérosclérose
|
|
US20130071415A1
(en)
|
2010-05-28 |
2013-03-21 |
Biocryst Pharmaceuticals, Inc. |
Heterocyclic Compounds as Janus Kinase Inhibitors
|
|
WO2012027494A1
(fr)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Réactifs bispécifiques de ciblage
|
|
WO2012027495A1
(fr)
|
2010-08-27 |
2012-03-01 |
University Of The Pacific |
Analogues de pipérazinylpyrimidine en tant qu'inhibiteurs de protéine kinase
|
|
DE202011110588U1
(de)
|
2010-09-20 |
2015-02-05 |
L'oréal |
Alkylcellulose-haltige wässrige kosmetische Zusammensetzung
|
|
PT2618811E
(pt)
|
2010-09-20 |
2015-04-13 |
Oreal |
Composição cosmética aquosa compreendendo alquilcelulose
|
|
AU2011323784A1
(en)
|
2010-10-25 |
2013-05-30 |
Regents Of The University Of Minnesota |
Therapeutic composition for treatment of glioblastoma
|
|
CN106278999B
(zh)
|
2011-02-07 |
2019-10-25 |
比奥根Ma公司 |
S1p调节剂
|
|
CA2865487A1
(fr)
|
2011-03-07 |
2012-09-13 |
Paula J. Bates |
Marqueur predictif de l'efficacite therapeutique de l'inhibiteur dnmt1, et procedes d'utilisation dudit marqueur
|
|
WO2012135697A2
(fr)
|
2011-03-30 |
2012-10-04 |
H. Lee Moffitt Cancer Center & Research Institute Inc. |
Nouveaux inhibiteurs de la rho-kinase et leurs procédés d'utilisation
|
|
CN103826657A
(zh)
|
2011-04-04 |
2014-05-28 |
衣阿华大学研究基金会 |
改进疫苗免疫原性的方法
|
|
WO2012139015A1
(fr)
|
2011-04-06 |
2012-10-11 |
Rutgers, The State University Of New Jersey |
Polymères et procédés pour le traitement de la douleur
|
|
US20120270860A1
(en)
|
2011-04-19 |
2012-10-25 |
Gihyun Yoon |
Methods for treating or preventing alcohol-related disorders or craving-related disorders
|
|
WO2012145678A1
(fr)
|
2011-04-20 |
2012-10-26 |
Regents Of The University Of Minnesota |
Composés parthénolides anticancéreux et anti-inflammatoire
|
|
US9415112B2
(en)
|
2011-06-20 |
2016-08-16 |
Rutgers, The State University Of New Jersey |
Bipartite inhibitors of bacterial RNA polymerase
|
|
WO2013009647A1
(fr)
|
2011-07-08 |
2013-01-17 |
Regents Of The University Of Minnesota |
Analogues du glutathion et leurs utilisations
|
|
AU2012287103B2
(en)
|
2011-07-22 |
2017-03-30 |
University Of Louisville Research Foundation, Inc. |
Anti-biofilm compounds
|
|
US9517229B2
(en)
|
2011-07-29 |
2016-12-13 |
Medivation Prostate Therapeutics, Inc. |
Treatment of breast cancer
|
|
WO2013028866A1
(fr)
|
2011-08-24 |
2013-02-28 |
Regents Of The University Of Minnesota |
Composés et méthodes thérapeutiques
|
|
US9034336B2
(en)
|
2011-08-30 |
2015-05-19 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
|
US9598441B2
(en)
|
2011-08-30 |
2017-03-21 |
Wayne State University |
Therapeutic compounds and methods
|
|
JP6258202B2
(ja)
|
2011-09-08 |
2018-01-10 |
ウェスタン ユニバーシティ オブ ヘルス サイエンス |
がん療法における標的リポソーム
|
|
JP2014527083A
(ja)
|
2011-09-15 |
2014-10-09 |
アリゾナ ボード オブ リージェンツ， ア ボディー コーポレイト オブ ザ ステート オブ アリゾナ， アクティング フォー アンド オン ビハーフ オブ アリゾナ ステート ユニバーシティー |
治療用化合物
|
|
US9828326B2
(en)
*
|
2011-12-27 |
2017-11-28 |
Northeast Ohio Medical University |
Amooranin compounds and analogs thereof and related methods of use
|
|
FR2985176B1
(fr)
|
2012-01-02 |
2015-05-29 |
Oreal |
Composition cosmetique liquide aqueuse comprenant de l'alkylcellulose, des huiles non volatiles et au moins un tensioactif
|
|
WO2013103969A1
(fr)
|
2012-01-05 |
2013-07-11 |
Rutgers, The State University Of New Jersey |
Agents antibactériens : dérivés du phloroglucinol
|
|
CA2862999A1
(fr)
|
2012-01-11 |
2013-07-18 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Fragments d'anticorps bispecifiques pour proteines associees a une maladie neurologique, et procedes d'utilisation
|
|
US8947424B2
(en)
|
2012-01-17 |
2015-02-03 |
Eastman Kodak Company |
Spectral stereoscopic projection system
|
|
EP2804606B1
(fr)
|
2012-01-19 |
2017-06-28 |
Hybrid Medical, LLC |
Préparations thérapeutiques topiques
|
|
US9296728B2
(en)
|
2012-01-20 |
2016-03-29 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
|
US20130195752A1
(en)
|
2012-02-01 |
2013-08-01 |
Regents Of The University Of Minnesota |
Functionalized nanoparticles and methods of use thereof
|
|
CA2863427C
(fr)
|
2012-02-01 |
2022-07-12 |
The Governors Of The University Of Alberta |
Utilisation de pdgfr-alpha en tant que marqueur de diagnostic pour le cancer de la thyroide papillaire
|
|
US9839634B2
(en)
|
2012-02-06 |
2017-12-12 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: combination of a rifamycin and a switch region inhibitor
|
|
EP2822548B1
(fr)
|
2012-02-08 |
2019-04-24 |
University of Virginia Patent Foundation |
Inhibiteurs de la kinase sphingosine avec base à longue chaîne
|
|
US9187446B2
(en)
|
2012-03-22 |
2015-11-17 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: sidechainfluorinated myxopyronin derivatives
|
|
WO2013148584A1
(fr)
|
2012-03-26 |
2013-10-03 |
University Of Iowa Research Foundation |
Analogues de schweinfurthines
|
|
WO2013158197A1
(fr)
|
2012-04-16 |
2013-10-24 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Dérivés de marinopyrrole comme agents anticancéreux
|
|
US9272016B2
(en)
|
2012-04-20 |
2016-03-01 |
University Of Iowa Research Foundation |
Methods to enhance RNAi oligonucleotide delivery to respiratory epithelial cells
|
|
CA2872751A1
(fr)
|
2012-05-07 |
2013-11-14 |
The Regents Of The University Of California |
Oxy133, un analogue de l'oxysterol, induisant l'osteo-genese et la signalisation hedgehog et inhibant l'adipogenese
|
|
EP2861570B1
(fr)
|
2012-06-19 |
2018-07-18 |
Rutgers, The State University of New Jersey |
Agents antibactériens : dérivés aryliques de la myxopyronine
|
|
US9492448B2
(en)
|
2012-06-20 |
2016-11-15 |
University Of Virginia Patent Foundation |
Compositions and methods for regulating glucose homeostasis and insulin action
|
|
US9669115B2
(en)
|
2012-06-29 |
2017-06-06 |
University Of Iowa Research Foundation |
Co-crystals and salts of contrast agents and imaging
|
|
AU2013286683B2
(en)
|
2012-07-05 |
2017-07-13 |
University Of Iowa Research Foundation |
Therapeutic bisphosphonates
|
|
JP6483610B2
(ja)
|
2012-07-18 |
2019-03-13 |
ユニバーシティ オブ ノートルダム デュ ラック |
５，５−ヘテロ芳香族抗感染症化合物
|
|
WO2014018671A1
(fr)
|
2012-07-24 |
2014-01-30 |
Regents Of The University Of Minnesota |
Composés thérapeutiques pour le traitement du cancer
|
|
ES2668694T3
(es)
|
2012-07-27 |
2018-05-21 |
Biogen Ma Inc. |
Derivados de ácido 1-[7-(cis-4-metil-ciclohexiloxi)-8-trifluorometil-naftalen-2-ilmetil]-piperidin-4-carboxílico como moduladores de autotaxina (ATX) para tratar inflamaciones y trastornos autoinmunitarios
|
|
BR112015002249A2
(pt)
|
2012-08-01 |
2017-07-04 |
Lewis And Clark Pharmaceuticals Inc |
composto, um estereoisômero ou sal farmaceuticamente aceitável do mesmo; composição farmacêutica; método para tratar um estado associado a receptor de adenosina a2a em um indivíduo; método para diagnosticar anormalidades de perfusão de miocárdio em um mamífero; e método para reduzir a pressão interocular em um indivíduo
|
|
CA2879798C
(fr)
|
2012-08-03 |
2022-05-31 |
The Board Of Trustees Of The University Of Illinois |
Derives de 2-(4-benzylpiperazin-1-yl)n'(2-hydroxybenzylidene)acetohydrazide substituee pro-caspase a activation d'enzymes et compositions connexes
|
|
EP2879673B1
(fr)
|
2012-08-06 |
2018-07-25 |
Biogen MA Inc. |
Dérivés de la naphthaline substitué 1,5,6 en tant que modulateurs du récepteur sphingosine 1 phosphate (S1P) et/ou autotaxin (ATX) pour le traitement de maladies d'inflammation et d'auto-immunité
|
|
ES2660287T3
(es)
|
2012-08-06 |
2018-03-21 |
Biogen Ma Inc. |
Compuestos que son agentes moduladores de s1p y/o agentes moduladores de atx
|
|
CA3139033A1
(fr)
|
2012-08-22 |
2014-02-27 |
Cornell University |
Methodes d'inhibition de la fascine
|
|
WO2014039860A2
(fr)
|
2012-09-07 |
2014-03-13 |
University Of Louisville Research Foundation, Inc. |
Compositions et méthodes de modulation de l'activité inhibitrice de la dnmt1
|
|
WO2014043252A2
(fr)
|
2012-09-11 |
2014-03-20 |
Rutgers, The State University Of New Jersey |
Hydroxypyridones, hydroxypyrimidinones et hydroxypyridazinones thérapeutiques
|
|
WO2014052237A1
(fr)
|
2012-09-26 |
2014-04-03 |
Aragon Pharmaceuticals, Inc. |
Anti-androgènes pour le traitement du cancer de la prostate non métastatique, résistant à la castration
|
|
EP2906207A4
(fr)
|
2012-10-10 |
2016-10-26 |
Univ Arizona State |
Agents d'extinction de radicaux multifonctionnels
|
|
WO2014059350A1
(fr)
|
2012-10-12 |
2014-04-17 |
Regents Of The University Of Minnesota |
Dérivés de 1,1 '-alkylène-bis-uracile à chaîne ouverte ou fusionnés, utiles dans la protection uv de la peau
|
|
WO2014066840A1
(fr)
|
2012-10-26 |
2014-05-01 |
Regents Of The University Of Minnesota |
Inhibiteurs d'aurora kinase
|
|
WO2014070774A1
(fr)
|
2012-10-29 |
2014-05-08 |
Southern Methodist University |
Procédés de génération de composés de carbapénem résistants à la bêta-lactamase
|
|
WO2014074926A1
(fr)
|
2012-11-09 |
2014-05-15 |
Rutgers, The State University Of New Jersey |
Hydroxyquinolones thérapeutiques
|
|
MX2015005949A
(es)
|
2012-11-16 |
2015-09-08 |
Biocryst Pharm Inc |
Nucleosidos que contienen aza-azucar antiviral.
|
|
CN105189492A
(zh)
|
2012-11-19 |
2015-12-23 |
萨克·W·金 |
麦角灵衍生物作为多巴胺受体调节剂
|
|
US9771326B2
(en)
|
2012-11-20 |
2017-09-26 |
Biogen Ma Inc. |
S1P and/or ATX modulating agents
|
|
ES2636596T3
(es)
|
2012-11-20 |
2017-10-06 |
Biogen Ma Inc. |
Agentes moduladores de S1P y/o ATX
|
|
EP2945628B1
(fr)
|
2013-01-15 |
2020-04-15 |
Aragon Pharmaceuticals, Inc. |
Modulateur du récepteur des androgènes en combinaison d'acetate d'abiraterone et de prednisone pour le traitement du cancer de la prostate
|
|
US9700044B2
(en)
|
2013-01-22 |
2017-07-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Symmetrical marinopyrrole derivatives as potential antibiotic agents
|
|
CA2899322A1
(fr)
|
2013-01-29 |
2014-08-07 |
Biogen Ma Inc. |
Agents modulateurs de s1p
|
|
US9981043B2
(en)
|
2013-02-08 |
2018-05-29 |
Regents Of The University Of Minnesota |
Analgesic conjugates
|
|
US9776975B2
(en)
|
2013-03-05 |
2017-10-03 |
University Of Notre Dame Du Lac |
Quinazolinone antibiotics
|
|
TW201446768A
(zh)
|
2013-03-15 |
2014-12-16 |
Biogen Idec Inc |
S1p及/或atx調節劑
|
|
US9387250B2
(en)
|
2013-03-15 |
2016-07-12 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions for bone repair
|
|
CA2906100A1
(fr)
|
2013-03-15 |
2014-09-18 |
Genentech, Inc. |
Traitement de maladies dans lesquelles interviennent les lymphocytes th2 par inhibition de bromodomaines
|
|
US9617282B2
(en)
|
2013-03-15 |
2017-04-11 |
Biogen Ma Inc. |
Macrocyclic compounds as IRAK4 inhibitors for the treatment of inflammatory diseases
|
|
JP2016517888A
(ja)
|
2013-05-02 |
2016-06-20 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
骨選択的骨形成のオキシステロール骨標的薬剤
|
|
US9862672B2
(en)
|
2013-05-29 |
2018-01-09 |
Rutgers, The State University Of New Jersey |
Antioxidant-based poly(anhydride-esters)
|
|
US9987211B2
(en)
|
2013-07-03 |
2018-06-05 |
Regents Of The University Of Minnesota |
Sunless tanning compounds and compositions
|
|
WO2015021149A1
(fr)
|
2013-08-06 |
2015-02-12 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibiteurs de la tyrosine kinase ack1/tnk2
|
|
CN106102758B
(zh)
|
2013-11-11 |
2020-09-22 |
夸利蒂赫布丘蒂克斯公司 |
卡瓦衍生的治疗性化合物及其使用方法
|
|
US9339482B2
(en)
|
2013-11-22 |
2016-05-17 |
Regents Of The University Of Minnesota |
Methods to treat dysregulated blood glucose disorders
|
|
US9315523B2
(en)
|
2013-12-06 |
2016-04-19 |
Rutgers, The State University Of New Jersey |
Cyclic dinucleosides
|
|
US9919998B2
(en)
|
2014-02-06 |
2018-03-20 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides
|
|
WO2015127125A1
(fr)
|
2014-02-20 |
2015-08-27 |
Cornell University |
Composés et procédés d'inhibition de la fascine
|
|
WO2015130805A1
(fr)
|
2014-02-26 |
2015-09-03 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Compositions de grille d'adn et procédés
|
|
US10272055B2
(en)
|
2014-03-06 |
2019-04-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
HRP20221373T1
(hr)
|
2014-03-07 |
2023-01-06 |
Biocryst Pharmaceuticals, Inc. |
Supstituirani pirazoli kao inhibitori kalikreina u ljudskoj plazmi
|
|
US10197575B2
(en)
|
2014-03-31 |
2019-02-05 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Stabilized peptoid-peptide hybrids and uses thereof
|
|
CA2946112C
(fr)
|
2014-04-18 |
2020-11-24 |
The Governors Of The University Of Alberta |
Therapie ciblee pour restaurer le transport de l'iode radioactif pour traiter le cancer de la thyroide
|
|
US9556113B2
(en)
|
2014-04-29 |
2017-01-31 |
The South Dakota Board Of Regents |
Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment
|
|
EP3137480A4
(fr)
|
2014-05-02 |
2017-11-29 |
The Regents of The University of California |
Analogues de bisphosphonates d'oxystérol ostéogéniques ciblant spécifiquement l'os
|
|
US9987299B2
(en)
|
2014-05-05 |
2018-06-05 |
University Of Iowa Research Foundation |
Methods of improving RNAi in well-differentiated airway epithelia
|
|
EP3152206A1
(fr)
|
2014-06-06 |
2017-04-12 |
Biogen MA Inc. |
Agents de modulation d'atx
|
|
WO2015195563A1
(fr)
|
2014-06-16 |
2015-12-23 |
Rutgers, The State University Of New Jersey |
Agents antibactériens
|
|
US9737598B2
(en)
|
2014-06-30 |
2017-08-22 |
Regents Of The University Of Minnesota |
CD200 inhibitors and methods of use thereof
|
|
KR102299276B1
(ko)
*
|
2014-07-16 |
2021-09-09 |
(주)아모레퍼시픽 |
납떼기콩 오일을 포함하는 조성물
|
|
US11149046B2
(en)
|
2014-08-19 |
2021-10-19 |
Hsiri Therapeutics, Inc. |
Antibacterial sideromycins
|
|
US11135178B2
(en)
|
2014-09-11 |
2021-10-05 |
University Of Iowa Research Foundation |
Thymol and carvacol for use in medicine
|
|
WO2016076929A1
(fr)
|
2014-11-13 |
2016-05-19 |
University Of Iowa Research Foundation |
Procédés pour générer des cellules épithéliales
|
|
CA2976776C
(fr)
|
2015-02-17 |
2023-06-20 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Analogues de phenothiazine utilises comme agents therapeutiques mitochondriaux
|
|
CA2976937C
(fr)
|
2015-02-17 |
2023-04-04 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Composes therapeutiques
|
|
US10507228B2
(en)
|
2015-04-20 |
2019-12-17 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Methods and compositions related to KRAS inhibitors
|
|
AU2016258123A1
(en)
|
2015-05-06 |
2018-01-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Radiotherapeutic and companion imaging agents to target MC1R
|
|
CN108026084A
(zh)
|
2015-05-07 |
2018-05-11 |
夸利蒂赫布丘蒂克斯公司 |
治疗化合物及其使用方法
|
|
EP3297655B1
(fr)
|
2015-05-18 |
2020-04-15 |
Arizona Board of Regents on Behalf of the University of Arizona |
Amélioration de la prévention du cancer par de nouvelles mélanotrines
|
|
WO2016205397A2
(fr)
|
2015-06-15 |
2016-12-22 |
Klibanov Alexander L |
Administration spécifique de cible d'agents thérapeutiques
|
|
WO2016205534A1
(fr)
|
2015-06-16 |
2016-12-22 |
Lazo John S |
Inhibiteurs de ptp4a3 pour le traitement du cancer
|
|
US10814006B2
(en)
|
2015-07-14 |
2020-10-27 |
University Of Iowa Research Foundation |
Fluorescent prodrugs
|
|
US10729669B2
(en)
|
2015-07-28 |
2020-08-04 |
University Of Iowa Research Foundation |
Compositions and methods for treating cancer
|
|
EP3328496A4
(fr)
|
2015-08-02 |
2018-12-19 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibiteurs de la tyrosine kinase ack1/tnk2
|
|
WO2017027883A1
(fr)
|
2015-08-13 |
2017-02-16 |
San Diego State University Research Foundation |
Atropisomérisme pour une sélectivité accrue des inhibiteurs de kinase
|
|
CA2997541C
(fr)
|
2015-09-04 |
2022-01-11 |
Janssen Pharmaceutica Nv |
Composes therapeutiques pour la douleur et synthese de ceux-ci
|
|
CA2999279A1
(fr)
|
2015-10-01 |
2017-04-06 |
Goleini Inc. |
Expression ciblee de canaux chlorure et procedes d'utilisation de celle-ci
|
|
FI4019022T3
(fi)
|
2015-10-01 |
2024-04-19 |
Biocryst Pharm Inc |
Ihmisen plasman kallikreiinin estäjiä
|
|
WO2017066428A1
(fr)
|
2015-10-13 |
2017-04-20 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Inhibiteurs de brd4-kinase à utiliser en tant qu'agents thérapeutiques anticancéreux
|
|
AU2016349897B2
(en)
|
2015-11-03 |
2021-11-04 |
Regents Of The University Of Minnesota |
CD200 inhibitors and methods of use thereof
|
|
CN119185322A
(zh)
|
2015-11-20 |
2024-12-27 |
生华生物科技股份有限公司 |
用于治疗癌症的四环喹诺酮类似物组合疗法
|
|
US9957282B2
(en)
|
2015-12-14 |
2018-05-01 |
Senhwa Biosciences, Inc. |
Crystalline forms of quinolone analogs and their salts
|
|
US9980951B2
(en)
|
2015-12-17 |
2018-05-29 |
University Of Iowa Research Foundation |
Image guided therapy for cancer
|
|
KR102108114B1
(ko)
|
2015-12-21 |
2020-05-11 |
로레알 |
알킬셀룰로오스, 불상용성 탄화수소 및 실리콘 오일을 포함하는 조성물 및 이의 이용 방법
|
|
TWI726969B
(zh)
|
2016-01-11 |
2021-05-11 |
比利時商健生藥品公司 |
用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
|
|
TWI747873B
(zh)
|
2016-02-01 |
2021-12-01 |
美商百歐克斯製藥公司 |
苯并吡唑化合物及其類似物
|
|
WO2017156527A1
(fr)
|
2016-03-11 |
2017-09-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibiteurs des kinases aurora et des janus kinases pour la prévention de la maladie du greffon contre l'hôte
|
|
CN109153644B
(zh)
|
2016-03-16 |
2022-10-21 |
H·李·莫菲特癌症中心研究有限公司 |
用以增强效应t细胞功能的针对cereblon的小分子
|
|
WO2017165558A1
(fr)
|
2016-03-22 |
2017-09-28 |
Regents Of The University Of Minnesota |
Combinaison pour traiter la douleur
|
|
WO2017165836A1
(fr)
|
2016-03-24 |
2017-09-28 |
Rutgers, The State University Of New Jersey |
Agents antibactériens
|
|
EP3442979A4
(fr)
|
2016-04-04 |
2019-12-18 |
Rutgers, the State University of New Jersey |
Poisons de topoisomérase
|
|
US10551384B2
(en)
|
2016-04-07 |
2020-02-04 |
Rutgers, The State University Of New Jersey |
MTOR kinase mutations and methods of use thereof
|
|
CA3247223A1
(en)
|
2016-04-18 |
2026-05-13 |
Kenneth Michael MORROW |
Isolation of plant extracts
|
|
US10426843B2
(en)
|
2016-05-04 |
2019-10-01 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer
|
|
US10899793B2
(en)
|
2016-05-27 |
2021-01-26 |
Regents Of The University Of Minnesota |
Melanocortin ligands and methods of use thereof
|
|
JP2019526617A
(ja)
|
2016-06-20 |
2019-09-19 |
ラトガース ザ ステイト ユニバーシティー オブ ニュージャージー |
治療用化合物
|
|
AU2017281940C1
(en)
|
2016-06-24 |
2024-11-07 |
University Of Iowa Research Foundation |
Compositions and methods of treating melanoma
|
|
EP3490552B1
(fr)
|
2016-07-26 |
2022-11-23 |
University of Southern California |
Inhibition sélective de bromodomaine de bdf1 fongique
|
|
US11390605B2
(en)
|
2016-08-25 |
2022-07-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Substituted pyrimidine compounds as multifunctional radical quenchers and their uses
|
|
MX2020012139A
(es)
|
2016-09-08 |
2021-01-29 |
Vyne Pharmaceuticals Inc |
Composiciones y metodos para tratar rosacea y acne.
|
|
BR112019007763A2
(pt)
|
2016-10-17 |
2019-07-02 |
Genentech Inc |
composto de fórmula, composição farmacêutica, métodos para tratar uma doença ou condição, para tratar dores, para diminuir o fluxo de íons e para tratar prurido, uso de um composto e invenção
|
|
US11124541B2
(en)
|
2016-10-18 |
2021-09-21 |
Regents Of The University Of Minnesota |
Chimeric melanocortin ligands and methods of use thereof
|
|
ES2942285T3
(es)
|
2016-10-31 |
2023-05-31 |
Biocryst Pharm Inc |
Profármacos de inhibidores de la calicreína
|
|
US11071747B2
(en)
|
2016-11-29 |
2021-07-27 |
University Of Iowa Research Foundation |
Use of NAD precursors for breast enhancement
|
|
EP3554285A4
(fr)
|
2016-11-29 |
2021-01-20 |
University of Iowa Research Foundation |
Utilisation de précurseurs de nad pour améliorer la santé maternelle et/ou la santé de la descendance
|
|
US10710957B2
(en)
|
2017-01-09 |
2020-07-14 |
University Of Central Florida Research Foundation, Inc. |
Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria
|
|
WO2018136792A1
(fr)
|
2017-01-20 |
2018-07-26 |
The Regents Of The University Of California |
Inhibiteurs du domaine n-terminal du récepteur d'androgène
|
|
US10231947B2
(en)
|
2017-01-23 |
2019-03-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Isochroman compounds and methods of use thereof
|
|
US10238655B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Dihydroindene and tetrahydronaphthalene compounds
|
|
US10238626B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
|
WO2018140504A1
(fr)
|
2017-01-24 |
2018-08-02 |
Patel Manoj K |
Compositions et procédés de blocage de canaux sodiques
|
|
US10294264B2
(en)
|
2017-04-21 |
2019-05-21 |
Warsaw Orthopedic, Inc. |
Oxysterol-therapeutic agent derivative for bone healing
|
|
CA3063174A1
(fr)
|
2017-05-12 |
2018-11-15 |
Innovus Pharmaceuticals, Inc. |
Methodes therapeutiques et compositions associees
|
|
US10434106B2
(en)
|
2017-05-19 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Oxysterol-statin compounds for bone growth
|
|
EP3630115B1
(fr)
|
2017-05-22 |
2025-12-10 |
University Of Virginia Patent Foundation |
Compositions et méthodes de préparation et d'utilisation de découpleurs mitochondriaux
|
|
AR112027A1
(es)
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
|
US20180371526A1
(en)
|
2017-06-23 |
2018-12-27 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Compositions and methods for detecting viral nucleic acids
|
|
EP3641776B1
(fr)
|
2017-06-23 |
2023-10-18 |
San Diego State University Research Foundation |
Atropisomérisme pour une sélectivité améliorée des inhibiteurs de kinase
|
|
WO2019046467A1
(fr)
|
2017-08-29 |
2019-03-07 |
Rutgers, The State University Of New Jersey |
Indazoles thérapeutiques
|
|
WO2019147308A2
(fr)
|
2017-08-30 |
2019-08-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Nanostructures arn et méthodes de fabrication et d'utilisation de nanostructures arn
|
|
CA3076233A1
(fr)
|
2017-10-06 |
2019-04-11 |
Blue Therapeutics, Inc. |
Methodes pour traiter la douleur aigue ou chronique
|
|
KR20240096623A
(ko)
|
2017-10-16 |
2024-06-26 |
아라곤 파마슈티컬스, 인코포레이티드 |
비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐
|
|
CA3082575A1
(fr)
|
2017-11-17 |
2019-05-23 |
The Board Of Trustees Of The University Of Illinois |
Traitement du cancer par degradation de la signalisation double de mek
|
|
CN111511757A
(zh)
|
2017-11-17 |
2020-08-07 |
细胞凝胶制药有限责任公司 |
μ阿片受体的聚合物激动剂
|
|
CN111683654A
(zh)
|
2017-11-30 |
2020-09-18 |
细胞凝胶制药有限责任公司 |
新型镇痛药物制剂及其用途
|
|
US11242533B2
(en)
|
2018-01-10 |
2022-02-08 |
Arizona Board Of Regents On Behalf Of Arizona State University |
RNA-nanostructured double robots and methods of use thereof
|
|
US10738093B2
(en)
|
2018-01-25 |
2020-08-11 |
The Hong Kong University Of Science And Technology |
Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining
|
|
CN112118837B
(zh)
|
2018-02-13 |
2024-07-09 |
罗格斯新泽西州立大学 |
抗菌剂：o-烷基氘化派洛宁
|
|
EP3752149A4
(fr)
|
2018-02-15 |
2022-03-02 |
Senhwa Biosciences, Inc. |
Analogues de quinolone, sels correspondants, compositions et procédé d'utilisation
|
|
WO2019168921A1
(fr)
|
2018-02-27 |
2019-09-06 |
University Of Virginia Patent Foundation |
Inhibiteur de liposomes/parp ciblés par plectine dans le traitement du cancer
|
|
US11572337B2
(en)
|
2018-03-06 |
2023-02-07 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: arylalkylcarboxamido phloroglucinols
|
|
TWI873092B
(zh)
|
2018-04-06 |
2025-02-21 |
美商百歐克斯製藥公司 |
取代的苯并呋喃、苯并吡咯、苯并噻吩及結構相關的補體抑制劑
|
|
EP3781567B1
(fr)
|
2018-04-20 |
2022-08-24 |
Virginia Tech Intellectual Properties, Inc. |
Imidazopyridines comme découpleurs mitochondriaux
|
|
WO2020036654A2
(fr)
|
2018-04-27 |
2020-02-20 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Topologies moléculaires hautement nouées à partir d'acides nucléiques monocaténaires
|
|
EP4556031A3
(fr)
|
2018-04-27 |
2025-06-25 |
University of Iowa Research Foundation |
Compositions pour la chélation de métaux à basses températures
|
|
WO2019246111A1
(fr)
|
2018-06-19 |
2019-12-26 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Virus oncolytique ou antigène présentant une thérapie anticancéreuse à médiation par des cellules utilisant un interféron de type i et un ligand cd40
|
|
US10758594B2
(en)
|
2018-06-26 |
2020-09-01 |
Marine Essence Biosciences Corporation of USA |
Biomaterial devices and topical compositions for treatment of skin abnormalities
|
|
US10912822B2
(en)
|
2018-06-26 |
2021-02-09 |
Marine Essence Biosciences Corporation of USA |
Biomaterial devices and topical compositions for guided tissue regeneration
|
|
EP3820532A4
(fr)
|
2018-07-11 |
2022-04-06 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Composés immunomodulateurs dimères visant des mécanismes à base de céréblon
|
|
US10898460B1
(en)
|
2018-07-20 |
2021-01-26 |
University Of South Florida |
Leishmania inhibitors
|
|
US11987568B2
(en)
|
2018-08-03 |
2024-05-21 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Allosteric inhibitor of WEE1 kinase
|
|
CA3109191A1
(fr)
|
2018-08-09 |
2020-02-13 |
The Board Of Trustees Of The University Of Illinois |
Composes d'imidazotetrazine
|
|
US11332499B2
(en)
|
2018-08-16 |
2022-05-17 |
Regents Of The University Of Minnesota |
Cyclic peptides and methods of use thereof
|
|
US12319685B2
(en)
|
2018-08-17 |
2025-06-03 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Small molecule pyrin-domain targeted NLRP3 inflammasome inhibitors
|
|
ES2906715T3
(es)
*
|
2018-09-06 |
2022-04-20 |
Marine Essence Biosciences Corp Of Usa |
Dispositivos de biomaterial para la regeneración de tejidos guiada
|
|
WO2020081917A1
(fr)
|
2018-10-18 |
2020-04-23 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibiteurs de βeta-caténine et de lymphomeà cellules b 9 (bcl9)
|
|
WO2020081918A2
(fr)
|
2018-10-18 |
2020-04-23 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibiteurs du lymphome 9 à βeta-caténine et à lymphocyte b (bcl9)
|
|
ES3069209T3
(en)
|
2018-11-07 |
2026-06-04 |
Univ Minnesota |
Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction
|
|
CN113302206A
(zh)
|
2018-11-26 |
2021-08-24 |
戴纳立制药公司 |
治疗脂质代谢失调的方法
|
|
EP3886848A4
(fr)
|
2018-11-27 |
2022-08-17 |
Rutgers, The State University of New Jersey |
Composés pharmaceutiques et méthodes thérapeutiques
|
|
WO2020118179A1
(fr)
|
2018-12-07 |
2020-06-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibiteurs peptidomimétiques de l'interaction protéine-protéine b-caténine/tcf
|
|
JP7663237B2
(ja)
|
2019-01-14 |
2025-04-16 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
がん免疫療法のためのｃｄ２００ａｒリガンド
|
|
US10889601B2
(en)
|
2019-02-11 |
2021-01-12 |
University Of Iowa Research Foundation |
Separations using boron containing hydrocarbon sponges
|
|
WO2020225779A1
(fr)
|
2019-05-09 |
2020-11-12 |
Istituto Pasteur Italia - Fondazione Cenci Bolognetti |
Agonistes de rig-i pour le traitement du cancer et l'immunothérapie
|
|
WO2020263989A1
(fr)
|
2019-06-24 |
2020-12-30 |
University Of Iowa Research Foundation |
Inhibiteurs de jnk en tant qu'agents anticancéreux
|
|
US11840703B2
(en)
|
2019-07-01 |
2023-12-12 |
Matrexa LLC |
Recombinant versican isoforms and related compositions and methods
|
|
EP4010320A4
(fr)
|
2019-08-06 |
2023-08-16 |
Biocryst Pharmaceuticals, Inc. |
Synthèse à l'échelle du processus d'un inhibiteur de la kallicréine plasmatique
|
|
TWI908740B
(zh)
|
2019-10-09 |
2025-12-21 |
美商百歐克斯製藥公司 |
口服補體因子d抑制劑
|
|
WO2021150928A1
(fr)
|
2020-01-23 |
2021-07-29 |
University Of South Florida |
Prévention et traitement des effets du vieillissement et de troubles associés à l'âge à l'aide d4+'une supplémentation en cétone
|
|
US12234578B2
(en)
|
2020-01-29 |
2025-02-25 |
Wisconsin Alumni Research Foundation |
Tannin composite fibers
|
|
US12552806B2
(en)
|
2020-03-20 |
2026-02-17 |
University Of Southern California |
Androgen receptor regulation by small molecule enantiomers
|
|
AR121715A1
(es)
|
2020-04-03 |
2022-06-29 |
Biocryst Pharm Inc |
Pirrolopirimidinaminas como inhibidores del sistema del complemento
|
|
WO2021211279A1
(fr)
|
2020-04-17 |
2021-10-21 |
Regents Of The University Of Minnesota |
Domaine de liaison au récepteur de spicule du sars-cov-2 et compositions et méthodes associées
|
|
US12318469B2
(en)
|
2020-06-30 |
2025-06-03 |
L'oréal |
Cosmetic compositions capable of forming a multilayer structure after application to a keratinous material containing a combination of silicone resins
|
|
US11529335B2
(en)
|
2020-07-31 |
2022-12-20 |
University Of Iowa Research Foundation |
Compositions and methods for treating cancer
|
|
US12630535B2
(en)
|
2020-08-14 |
2026-05-19 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibitors of ACK1/TNK2 tyrosine kinase
|
|
WO2022036313A1
(fr)
|
2020-08-14 |
2022-02-17 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Pyrimidinyl-sulfonamides en tant qu'inhibiteurs de la tyrosine kinase ack1/tnk1
|
|
US12617787B2
(en)
|
2020-11-30 |
2026-05-05 |
Lee Moffitt Cancer Center and Research Institute, Inc. |
Merged scaffold TAF1 inhibitors
|
|
WO2022155332A1
(fr)
|
2021-01-13 |
2022-07-21 |
Blue Therapeutics, Inc. |
Méthodes de traitement du syndrome du côlon irritable
|
|
EP4294805A1
(fr)
|
2021-02-22 |
2023-12-27 |
Regents of the University of Minnesota |
Immunomodulateurs et conjugués immunomodulateurs
|
|
US12303564B2
(en)
|
2021-03-19 |
2025-05-20 |
Wisconsin Alumni Research Foundation |
Composite chitosan-tannin-active agent compositions and methods of making and using same
|
|
JP2022151457A
(ja)
*
|
2021-03-26 |
2022-10-07 |
株式会社ピカソ美化学研究所 |
皮膚用組成物
|
|
EP4334309A1
(fr)
|
2021-05-04 |
2024-03-13 |
Regents of the University of Minnesota |
Composés et procédés contraceptifs
|
|
US12447135B2
(en)
|
2021-10-11 |
2025-10-21 |
University Of South Florida |
Fenchol as a stimulator of free fatty acid receptor and other uses thereof
|
|
US20250025447A1
(en)
|
2021-11-03 |
2025-01-23 |
Regents Of The University Of Minnesota |
Toll-like receptor agonists and antagonists and uses thereof
|
|
WO2023091689A1
(fr)
|
2021-11-19 |
2023-05-25 |
University Of Iowa Research Foundation |
Utilisation associée de radiothérapie dirigée par mcr1 et d'inhibition du point de contrôle immunitaire dans le traitement d'un mélanome
|
|
US20250376477A1
(en)
|
2022-07-01 |
2025-12-11 |
University Of Southern California |
Analgesic delta opioid receptor bitopic ligands
|
|
WO2024009283A1
(fr)
|
2022-07-07 |
2024-01-11 |
University Of Southern California |
Antagonistes at2 pour soulager la douleur non addictive
|
|
EP4551572A1
(fr)
|
2022-07-08 |
2025-05-14 |
Actio Biosciences, Inc. |
Composés et méthodes thérapeutiques
|
|
WO2024054678A2
(fr)
|
2022-09-09 |
2024-03-14 |
Regents Of The University Of Minnesota |
Anticorps dirigés contre le fentanyl et ses analogues et leurs procédés d'utilisation
|
|
WO2024102342A1
(fr)
|
2022-11-10 |
2024-05-16 |
University Of Iowa Research Foundation |
Combinaison d'un inhibiteur de la synthèse du glutathion tel que la buthionine sulfoximine et d'un inhibiteur de point de contrôle immunitaire, de préférence le pembrolizumab, pour traiter le cancer, de préférence un mélanome résistant aux médicaments
|
|
US20260207612A1
(en)
|
2022-11-23 |
2026-07-23 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
|
EP4630401A2
(fr)
|
2022-12-07 |
2025-10-15 |
Rutgers, the State University of New Jersey |
Inhibiteurs d'enzyme anhydrase carbonique et leurs procédés d'utilisation
|
|
WO2024197165A1
(fr)
|
2023-03-21 |
2024-09-26 |
University Of Iowa Research Foundation |
Composés céto-alkyl-pyridinium antifongiques à large spectre
|
|
WO2024206284A2
(fr)
|
2023-03-27 |
2024-10-03 |
Rutgers, The State University Of New Jersey |
Composés thérapeutiques
|
|
WO2024226603A1
(fr)
|
2023-04-24 |
2024-10-31 |
Regents Of The University Of Minnesota |
Composés thérapeutiques
|
|
US20250186630A1
(en)
|
2023-12-12 |
2025-06-12 |
Viewpoint Molecular Targeting, Inc. |
Fibroblast activation protein targeting peptides
|
|
WO2025259601A1
(fr)
|
2024-06-10 |
2025-12-18 |
Nemagen Discoveries, Inc. |
Inhibiteurs d'enzyme anhydrase carbonique et leurs procédés d'utilisation
|
|
WO2026060616A1
(fr)
|
2024-09-20 |
2026-03-26 |
Fulcrum Therapeutics, Inc. |
Inhibiteurs de phénothiazine et de phénoxazine calmoduline et leurs procédés d'utilisation
|
|
WO2026076223A1
(fr)
|
2024-10-03 |
2026-04-09 |
Regents Of The University Of Minnesota |
Composés thérapeutiques et leurs méthodes d'utilisation
|
|
WO2026139137A1
(fr)
|
2024-12-27 |
2026-07-02 |
Kupando Gmbh |
Formes cristallines d'un agoniste tlr4 et procédés pour les préparer
|